AlloCyte Pharmaceuticals AG is a Swiss-based company discovering, developing and commercializing next generation oral integrin modulators of allosteric mode of action protecting the integrity of tissues afflicted by autoimmunity. The next target milestone is clinical therapeutic proof-of-concept.
Some insights
A team who developed market leading medications before.